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Highlights:  
-Prenatal cigarette smoke exposure (SE) affected BDNF & TrkB in the XII of P20 mice. 
-Only PAC1 expression was increased by SE, with no effect on  PACAP. 
-There were no changes in GFAP or IBA-1 expression after SE in the nuclei studied. 
- The XII & NTS were the nuclei predominantly affected in this study. 
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Abstract: 
Cigarette smoke exposure during pregnancy into infancy affects brain growth and 
development in both short and long term (into adulthood). Using a mouse model of pre- into 
post- natal cigarette smoke exposure (SE), we aimed to determine the effects on brain derived 
neurotrophic factor (BDNF) and its receptor TrkB, neuropeptide pituitary adenylate cyclase 
activating polypeptide (PACAP) and its receptor PAC1, and astrocyte (GFAP) and microglia 
(Iba-1) immunohistochemical expression, in seven nuclei of the medulla and the facial (FAC) 
nucleus of the pons. Male pups of dams exposed to two cigarettes (nicotine <1.2mg, CO 
<15mg) twice daily for six weeks prior to mating, during gestation and lactation (n=5; SE), 
were compared to pups exposed to air under the same condition (n=5; SHAM) at postnatal day 
20. Expression changes were only evident for BDNF, TrkB and PAC1 and included decreased 
BDNF in the hypoglossal (XII) nucleus and nucleus of the solitary tract (NTS), increased 
TrkB in XII but decreased TrkB in the FAC, and increased PAC1 in 4 nuclei of the medulla 
including the NTS. These results suggest that the effect of SE on the brainstem are region and 
marker selective, affecting regions of respiratory control (XII and NTS), and restricted to the 
BDNF system and PAC1, with no effect on activation states of astrocytes or microglia.   
 
Keywords: Iba-1, GFAP, nicotine, PAC1, Sudden Infant Death Syndrome (SIDS), TrKB. 
 
Abbreviations:  
BDNF, brain derived neurotrophic factor; Cun, cuneate nucleus; DMNV, dorsal motor nucleus 
of the vagus; FAC, Facial nucleus; GFAP, glial fibrillary acidic protein; Iba-1, ionized 
calcium-binding adaptor molecule 1; IHC, immunohistochemistry; ION, inferior olivary 
nucleus; LRt, Lateral Reticular Nucleus; NSTT, nucleus of the spinal trigeminal tract; NTS, 
nucleus of solitary tract; PACAP, Pituitary Adenylate Cyclase Activating Polypeptide; SIDS, 
sudden infant death syndrome; XII, hypoglossal nucleus 
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1.  Introduction 
Cigarette smoking during pregnancy is associated with a number of adverse prenatal 
conditions such as low birth weight (Bernstein et al, 2005), still birth (Wisborg et al, 2001) 
and preterm delivery (Fantuzzi et al, 2008), as well as postnatal adversities including altered 
brain growth and development (reviewed Chang et al., 2014), and increased physiological 
dysfunction related to the cardiovascular, respiratory, sleep and arousal systems (reviewed by 
Vivekanandarajah et al., 2018), including an incidence of asthma and wheezing (Gilliland et al 
2001), impaired pulmonary function (Di Franza et al, 2004), altered cardiac responses during 
hypoxic conditions (Sovik et al., 2001) and increased risk for Sudden Infant Syndrome (SIDS) 
(Hoffman et al, 1988).  
 
Data from our laboratory suggests that these postnatal adversities are in part, due to abnormal 
regulation of the nicotinic acetylcholine receptors (nAChRs) in brainstem centres, as found in 
infants who died of SIDS with a known history of cigarette smoke exposure (Machaalani et 
al., 2011, Aisha et al., 2019), and in infant mice from mothers exposed to cigarette smoke 
(Vivekanandarajah et al., 2016). In both cohorts, the final cellular outcome was found to be 
increased cell death (apoptosis) (infants: Machaalani et al., 2007, Machaalani and Waters 
2008, mouse model: Vivekanandarajah et al., 2016). Subsequent studies from our laboratory 
to determine the pathways of cigarette smoke exposure induced apoptosis indicated a role of 
abnormal expression of the growth factor, brain derived neurotrophic factor (BDNF) (Tang et 
al., 2012), and of the neuropeptide pituitary adenylate cyclase activating polypeptide 
(PACAP) (Huang et al., 2017a), with both being specific to the hypoglossal nucleus of the 
medulla. 
 
A likely mechanism leading from the activation of the nAChRs to abnormal BDNF and 
PACAP expression, and to the final step of apoptosis of the cell, is neuroinflammation and 
oxidative stress. Astrocytes and microglia, play an important role in neuroinflammation 
(reviewed Liberman et al., 2018). Glial fibrillary acidic protein (GFAP) is a marker used to 
identify activated astrocytes, while ionized calcium-binding adaptor molecule 1 (Iba-1) is used 
to identify activated microglia. To date, no study has looked at the activation of these cell 
types in the brainstem of humans or animal models of pre-into –postnatal cigarette smoke 
exposure on the developing offspring. The only studies available are those using pure nicotine 
administration (pre or post-natally) and investigating the expression in higher cortical brain 
regions in adulthood (Summarized Table 1). 
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Using a mouse model of pre-into postnatal maternal cigarette smoke exposure (SE), this study 
aimed to determine the effects on the expression of BDNF, its tyrosine kinase receptor (TrkB), 
PACAP and its receptor polypeptide type 1 receptor (PAC1), GFAP and Iba-1, in the 
brainstem medulla and facial nucleus of the pons of the male off-spring at postnatal day 20. 
Our hypothesis was that the BDNF and PACAP would be decreased in nuclei of respiratory 
regulation, and this would be associated with an increase in astrocytes (GFAP) and microglia 
(Iba-1).  
2. Methods  
2.1. Maternal cigarette smoke exposure 
The exposure regime was as we have detailed previously (Vivekanandarajah et al.,2016, Chan 
et al., 2016a, b). The protocol was performed according to the Australian National Health & 
Medical Research Council Guide for the Care and Use of Laboratory Animals and was 
approved by the Animal Care and Ethics Committee at the University of Technology Sydney 
(ACEC#2011-313A).  
 
Briefly, virgin Balb/c mice (6 weeks) were obtained from Animal Resources Center (Perth, 
Australia), and housed at 20±2°C being maintained on a 12-h light, 12-h dark cycle (lights on 
at 06:00 h) with ad libitum access to standard laboratory chow and water. The mice were 
randomly assigned to sham (SHAM) or cigarette smoke exposure (SE) groups and had this 
delivered in a perspex chamber of 15L (40 x 27 x 20 cm) at room temperature. The SE group 
were exposed to two standard regular cigarettes (Winfield Red, nicotine < 1.2 mg, CO < 15 
mg, Philip Morris, VIC, Australia) twice daily (10:00h and 15:00h) for six weeks prior to 
mating, during gestation and lactation, and this was delivered for 15 minutes, with a 5-minute 
interval between the two cigarettes. The SHAM mice were placed in a separate identical 
perspex chamber to avoid any contamination and air exposure delivered under the same 
condition. All females were mated with non-cigarette smoke exposed 8 week old male Balb/c 
mice from the same source.  
2.2. Tissue Collection 
At postnatal day 20 (P20; normal weaning age), male offspring were anesthetized with 4% 
isofluorane and then sacrificed by decapitation. We focused on male mice as it has been 
shown that in this model, male offspring are more vulnerable to the impact of maternal SE 
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than females (Chan et al., 2016a). The brain stem with cerebellum intact, was collected and 
fixed with 10% formalin, rinsed in 70% ethanol and processed to paraffin embedding. Tissue 
blocks were sectioned at 4 μm by a rotary microtome (Shandon Finesse 325, Thermo Fisher 
Scientific Inc, Massachusetts, USA), mounted onto silanized slides, dried overnight at 45 °C 
and stored at room temperature in a dust-free environment for immunohistochemical staining.  
2.3. Immunohistochemistry (IHC) 
Sections from all cases were stained within the same experimental run for each respective 
antibody to avoid day-to-day variation. Duplicate staining was performed on 20% of cases to 
verify the reproducibility of results. IHC method is standard for our laboratory and is detailed 
in Tang et al., 2012 and Huang et al., 2017a. The antibodies used are summarized in Table 2. 
 
Briefly, all steps were performed at room temperature unless otherwise noted. Tissue sections 
were deparaffinised to distilled H2O and heat-induced epitope retrieval was applied by 
microwaving on ‘high’ (Homemaker; EM925ENV; 900W) in 10% TRIS-EDTA antigen 
retrieval buffer (1 mM EDTA, 1 mM sodium citrate, 2 mM Tris, pH 9.0) for 14 min. After 
cooling and rinsing with distilled water, sections were washed with phosphate buffered saline 
(PBS), a hydrophobic barrier was drawn surrounding the sections and endogenous hydrogen 
peroxidase quenched in 50% PBS, 50% methanol and 3% H2O2 for 15 min at room 
temperature, followed by two washes in PBS. Sections were blocked by 10% normal horse 
serum (NHS) in PBS for 30 min then incubated with primary antibodies (Table 2) overnight at 
room temperature. Negative controls were incubated with 1% NHS only. After two PBS 
washes on day 2, sections were incubated with biotinylated anti-rabbit secondary 
antibody made in horse (BA-1100, Vector Laboratories Inc., California, USA) for 1 hour and 
then in avidin-biotin complex (ABC) (VEPH4000, Vector Laboratories Inc., California, USA) 
for 1 hour. The sections were color-labelled with 3,3’-diaminobenzidine (DAB) (VESK4100, 
Vector Laboratories Inc., California, USA), followed by counterstaining with Harris’s 
Haematoxylin, dehydration through graded ethanol to xylene, mounted with Di-n-butyl 
Phthalate in Xylene (DPX) and coverslipped.  
 
2.4. Quantitative Analysis 
Nuclei of interest in the caudal medulla and pons were identified and imaged with reference to 
The Mouse Brain Atlas (Fig. 94 & 79-83 respectively; Paxinos & Franklin, 2004). Seven nuclei 
at the caudal medulla [hypoglossal nucleus (XII), dorsal motor nucleus of the vagus (DMNV), 
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nucleus of the solitary tract (NTS), cuneate nucleus (Cun), nucleus of the spinal trigeminal tract 
(NSTT), lateral reticular nucleus (LRt), and inferior olivary nucleus (ION)], and the facial 
nucleus (FAC) of the pons were studied.  
 
For BDNF, TrkB, PACAP and PAC1, staining was imaged with a DCF 400 (Leica 
Microsystems Ltd. Heerbrugg, Switzerland) mounted on a Leica DM6000 Nikon Upright at 20x 
magnification and captured using the Leica application suite software (LAS V3.8, Leica 
Microsystems Ltd., Heerbrugg, Switzerland). Quantification was of neurons only since these 
were the predominant cell type stained for these markers (Figure 1). Neurons in each nucleus 
were quantified blinded to the study group, using the cell counter function in ImageJ software 
(National Institutes of Health, USA). Positively and negatively stained neurons in each nucleus 
were counted manually and the percent of positive neurons for each region was calculated. 
Neurons with brown coloured somata were deemed positive, while neurons with lighter staining 
similar to the connective tissue staining colour, or blue due to the haematoxylin counter stain, 
were deemed negative. 
 
For GFAP, staining was imaged at 10x magnification and analysis was of the percentage of 
total area of positive staining in each nucleus via the color, deconvolution, threshold, and 
measure function using ImageJ software. For Iba-1, staining was assessed at 40x 
magnification and was a count of the number of positive cells per region analysed. Values 
were then exported into excel for calculation.  
 
2.5. Statistical Analysis 
The anthropometry results and the immunohistochemistry data are presented as the mean ± 
standard error of the mean (SEM). Statistical analysis was performed using one-way analysis 
of variance (ANOVA) (IBM SPSS Statistics 24 for Windows. IBM Corp., USA) comparing 
offspring from the maternal SE group (n=5) to the SHAM controls (n=5); offspring from the SE 
group were from 4 different litters, while those from the SHAM group were from 2 different 
litters. No adjustment for this was made statistically. A p-value <0.05 was considered 
significant. 
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3. Results 
3.1. Mouse characteristics  
As reported previously (Vivekanandarajah et al., 2016), SE mice had decreased body (9.96 ± 
0.44 vs 11.44 ± 0.28 grams, p = 0.01) and brain (0.27 ± 0.00 vs 0.29 ± 0.00 grams, p= 0.003) 
weight when compared to Sham. These are common features of offspring from smoking 
mothers (reviewed in Abbott and Winzer-Sehan, 2012). Level of smoke exposure was 
determined via serum cotinine which was found to be significantly higher in SE pups (8.93 ± 
0.87 vs 2.52 ± 0.35 ng/mL; p<0.001). This level is within the range reported in human infants 
of smoking mothers (5 to 30ng/ml; Luck and Nau 1985) with levels <5ng/ml indicative of 
background noise (Luck and Nau 1985, Benowitz et al., 2009).   
3.2. BDNF, TrkB, PACAP and PAC1 expression  
All nuclei studied had some expression for all these markers. Based on the SHAM group, 
BDNF and TrkB expression ranged from 20-40% amongst the nuclei while for PACAP and 
PAC1, this ranged from 40-80% (Figure 2).  
 
Comparing SE to SHAM mice, for BDNF, there was a decrease in the XII (p=0.03) and NTS 
(p=0.04), and an increase in the ION (p=0.05) (Figure 2). For TrkB, expression was increased 
in the XII (p=0.02) and decreased in the FAC (p=0.005). For PACAP, no changes were 
evident, whereas for PAC1, expression was increased in the NTS (p=0.009), Cun, NSTT and 
ION (p<0.05) (Figure 2). 
 
3.3. GFAP and Iba-1 expression 
GFAP staining (Figure 1) was seen in all mice and in all nuclei studied and ranged from 0.5-
1.5 percent area of expression (Figure 2). For Iba-1, expression was low and not observed in 
all mice, with 3 SHAM and 2 SE mice showing some expression in the regions studied.  
 
Comparing SE to SHAM mice, there was no difference in expression levels for either GFAP 
or Iba-1 (Figure 2).  
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4. Discussion 
The main findings of this study, which is the first to be conducted in the brainstem at early 
post-natal age, is that pre-into post-natal cigarette smoke exposure only affected BDNF, TrkB 
and PAC1 expression in select nuclei of the brainstem including the XII and NTS, both of 
which play an important role in respiratory control.   
 
4.1. Expression in the normal developing mouse brainstem  
This study is unique in that it is the first to report the protein IHC expression of all these markers 
simultaneously in the mouse brainstem. Regarding BDNF and TrkB expression, the overall 
average levels were 30% in the mouse medulla. This is lower than what we previously found in 
the human infant (averaged 50%; Tang et al., 2010) and young piglet (averaged 60%; Tang et 
al., 2008). The most likely explanation for this is that, at P20, these mice were past the greatest 
developmental brain growth period, which in rats regarding highest BDNF expression in the 
brainstem, occurs at P7-10, while for TrkB occurs at P10-11 (Lui and Wong Riley, 2013).    
 
For PACAP, the average percentage expression in the mouse was 70% which is similar to the 
piglet (Huang et al., 2017b) and lower than the human (90%; Huang et al., 2017a) when 
excluding the NTS as it had very low expression (Huang et al., 2017a,b). For PAC1, the average 
was 40% in the mouse, similar to the 30% average in human (Huang et al., 2017a), and 50% in 
piglets (Huang et al., 2017b). 
 
The higher expression of PACAP/PAC1 compared to BDNF/TrkB found in our mice, consistent 
with human and piglet studies detailed above, suggests that during development, neurons of 
most brainstem medullary nuclei require more PACAP than BDNF for growth and 
development. This is further supported by work in the rat brainstem medulla where the optical 
density for PACAP averaged 0.4 (Lui and Wong Riley 2019), but for BDNF/TrkB it averaged 
0.3 (Lui and Wong Riley 2013), representing a 25% difference.  
 
Baseline levels of GFAP were lowest in the motor nuclei of the XII and FAC of the P20 mice, 
and is similar to the low expression reported in these nuclei in mice aged 8 months (Kadoyama 
et al., 2007). Iba-1 was not seen in most of the mice in this study. For the mice with some Iba-
1, expression, this was low in all the nuclei studied yet was highest in the XII and FAC. 
Similarly, higher Iba-1 than GFAP in these nuclei was reported in mice aged 8 months 
(Kadoyama et al., 2007). Combined, this suggests that the astrocyte population in these nuclei 
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is smaller than the microglia population through to adulthood. 
4.2. Effects of pre- into post-natal SE on expression levels 
We recently reviewed the effects of SE and nicotine on BDNF and TrkB expression and showed 
that all previous studies were of cortical regions, the striatum, or the hippocampus (Machaalani 
and Hui 2018). No other studies have looked at SE on PACAP and PAC1 with the exception of 
our group where we report these within the brainstem of piglets exposed to nicotine postnatally 
(BDNF/TrkB- Tang et al., 2008; PACAP/PAC1 - Huang et al., 2017b) as well as human infants 
exposed to SE (BDNF/TrkB- Tang et al., 2012; PACAP/PAC1 - Huang et al., 2017a). 
 
Our finding that the XII had altered BDNF and TrkB expression in the SE mice, is consistent 
with our finding in human infants (Tang et al., 2012) and piglets exposed to postnatal nicotine 
alone (Tang et al., 2008), albeit the direction of change was the opposite. The combined 
decreased BDNF and increased TrkB in the XII of our mice suggests a coordinated action of 
agonist and receptor, where an increase in TrkB could be the adaptive cellular response to 
lower BDNF, and could be considered as a protective compensatory effect promoting 
neuroprotection by increasing receptor availability.  
 
Finding PAC1 was increased in four nuclei within this study is surprising when considering 
we saw no change in its expression in infants exposed to cigarette smoke (Huang et al., 2017a) 
while in our piglets, nicotine decreased PAC1 in the DMNV only (Huang et al., 2017b). 
Furthermore, it is surprising that the changes were not associated with alteration in PACAP 
given the PAC1 receptor is relatively selective (1000x higher affinity) for PACAP than for 
vasoactive intestinal polypeptide (VIP) (Vaudry et al., 2000). Given the lack of any other 
studies that have looked at cigarette smoke or nicotine effects on PAC1, we can only 
hypothesize that the increase in PAC1 expression in our P20 mice could be via the MAP 
kinase pathway since it regulates PAC1 promoter activity, despite the absence of PACAP 
treatment effect on it (Jamen et al., 2002). This could subsequently lead to the activation of the 
downstream intracellular pathways via Gαs coupling to adenylate cyclase leading to an 
increase in protein kinase A (PKA) (reviewed Dickson and Finlayson, 2009), or the PKC to 
release calcium (reviewed Farnham and Pilowski, 2010).  
 
The combined increase in PAC1 and decrease in BDNF in the NTS, as well as increased 
PAC1 and increased BDNF in the ION are interesting suggesting that any abnormal 
physiologies related to these nuclei in relation to SE exposure, is due to abnormalities in both 
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PAC1 and BDNF. Indeed, a relationship between PAC1 and BDNF has been reported and 
include: 1- decreased BDNF expression (but no change in TrkB) in PAC1 knockout mice 
(Zink et al., 2004), 2- BDNF treatment stimulated PAC1 promotor activity in cultured 
cerebellar cells (Jamen et al., 2002), and 3- a negative correlation between BDNF and PAC1 
expression after antidepressant treatments (Reichenstein et al., 2008). 
 
 
Based on the limited literature available for the effects of maternal SE and nicotine exposure 
on GFAP and Iba-1 expression (summarized table 1), the overall consensus is that prenatal 
cigarette smoke exposure has no real effect on GFAP or Iba-1 expression in the adult rodent 
brain, yet specific postnatal nicotine exposures increase the expression. Our study is consistent 
with the prenatal exposures having no effect (Chang et al., 2013, Zelikoff et al., 2018) and 
indicative that astrocytes and microglia levels are stable in the brainstem of mice at P20 after 
long term SE exposure, and that neuroinflammatory processes are not active. 
 
4.3 Nuclei affected and correlation with apoptosis and nicotine acetylcholine receptors 
(nAChRs) 
The three nuclei that were predominantly affected (that is, had a change in more than one 
marker) by the SE exposure in this study, were the XII, NTS and ION. Combining the data 
with that from our study of apoptotic and nAChR expression in these same mice 
(Vivekanandarajah et al., 2016), the following changes are present in these nuclei: 
1- XII- decreased BDNF, increased TrkB, increased active caspase-3, and an increase in 
the nAChR subunits α3, α4, α7, and α9, 
2- NTS- decreased BDNF, increased PAC1, no change in apoptosis, an increase in the α3 
and α5 but decrease in α4 nAChR subunits, 
3- ION- increased BDNF, increased PAC1, decreased active caspase-3 and TUNEL, no 
change for the nAChR subunits.  
 
Thus, for the XII and NTS, it can be concluded that the effects of maternal SE on BDNF and 
PAC1 are closely related to the interaction with several nAChR subunits. This is consistent 
with findings where PAC1 activated adenylate cyclase- (AC-) and phospholipase-C- (PLC) 
dependent transduction cascades (Margiotta and Pardi, 1995, Pardi and Margiotta, 1999) 
resulting in signaling that regulated both heteromeric nAChRs (containing α3, α5, β4, ± β2 
subunits) and homomeric α7 nAChRs, and mobilized intracellular calcium (Margiotta and 
Pardi, 1995, Pardi and Margiotta, 1999). The increase in cellular calcium influx could 
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subsequently be toxic leading to cell death (apoptosis). These changes would ultimately lead 
to altered physiologies which for the XII would include abnormal regulation of the upper 
airway muscles including the genioglossus (Boone and Aldesm 1984), and for the NTS would 
include abnormal cardiorespiratory control (reviewed Dampney 1994). For the ION, which is 
involved in the coordination of movement and balance (Bengtsson and Hesslow, 2006), the 
alteration in BDNF and PAC1 are independent of the nAChRs which suggests that these are 
due to other (non-nicotine) toxic components of cigarette smoke of which there are over 4800 
(Green and Rodgman 1996).  
 
5. Conclusion 
The results of this study show for the first time that at P20, pre-into post-natal cigarette smoke 
exposure only affected BDNF, TrkB and PAC1 expression in select nuclei of the brainstem in 
mice, including the XII and NTS, both of which play an important role in respiratory control. 
The lack of any change in GFAP and Iba-1 expression suggests neuroinflammatory pathways 
may not have been activated or have reached stable conditions due to the long-term exposure. 
These results provide further evidence of the lasting adverse effects of prenatal cigarette 
smoke exposure on the proteins important for growth and development of the brain especially 
to regions of specific respiratory control. 
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Figure Legends  
Figure 1: Representative images of the immunohistochemical staining for the markers in the 
hypoglossal (XII) and DMNV (A-D) of the same mouse, and Cun (E,F) nucleus. Positive 
staining for the marker is indicated by brown colour. Scale bar represents 100µm for A-D, and 
50µm for E,F. 
 
Figure 2: Comparison of the expression of the markers between SHAM (white bars, n=5) and 
SE (black bars, n=5) mice in 7 nuclei of the caudal medulla and the facial (FAC) nucleus of 
the pons. Results are presented as mean ± SEM. *p<0.05, **p<0.01. 
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Table 1: Summary of studies looking at GFAP and Iba-1 after cigarette or nicotine exposure. 
Exposure 
Model 
  
Species, Sex & 
Developmenta
l age 
Brain 
region(s) 
Microglia 
and 
Astrocyte 
marker  
Results References 
Prenatal exposures     
Prenatal s.c. 
Minipump 
nicotine 
(3.3mg/kg/day
) 
P30 and P60 
male & 
female rats 
cortex, 
hippocampus, 
thalamus and 
cerebellum 
GFAP  ↑ GFAP in CA1 
hippocampus 
and cerebellum 
associated with 
↑ cell death 
Abdel-
Rahman 
2005 
Prenatal s.c. 
osmotic 
Minipump 
nicotine 
(1.5mg/kg/day
) 
P15 male rats hypothalamus 
Iba-1, 
GFAP  
No changes. Chang et al., 2013 
Pre-into 
postnatal e-
cigarette (with 
vs without 
nicotine) 
P20 mice (3F, 
3 M) 
Hippocampus
and frontal 
cortex  
Iba-1, 
GFAP 
↑ Iba-1 in CA1 
of non-nicotine 
e-cigarette. No 
change for 
GFAP. 
Zelikoff et 
al., 2017 
Postnatal exposures     
Chronic 
nicotine 
exposure [i.p 
injection of 
1mg/kg, 5 
times a day, 4 
weeks] 
P30 male rats Cerebral cortices 
anti-OX-6 
(specific for 
major 
histocompat
ibility 
complex 
class II) 
for 
microglia  
↑ number of 
microglia  
Park et al., 
2007 
(NNK) 
tobacco-
specific 
procarcinogen 
injections for 4 
or 12 days 
6week adult  
male & 
female mice 
Cortex and 
hippocampus 
Iba-1, 
GFAP 
↑ for both Ghosh et al., 2009 
4% (v/v, 
smoke/air) 
[smoke=11 mg 
Tar, 0.8 mg 
Nicotine], 
1hr/day for 56 
days 
P35-40 male 
rats 
Cortex. 
Western 
blotting. 
Iba-1, 
GFAP 
No changes Lau et al., 2012 
Maternal 
osmotic 
minipump 
P180 (adults) hypothalamus 
Iba-1; 
CX3CR1 
(microglia 
↑ for all. 
Younes-
Rapozo et 
al., 2015 
  
 
14 
during 
lactation of 
nicotine 
6mg/kg/day 
receptor); 
GFAP 
10.4mg/kg/day 
nicotine s.c. 
osmotic pump 
Adult male 
rats 
NSTT, 
medullary 
horn spinal 
cord 
Iba-1; 
GFAP 
↑ for both. Hawkins et al., 2015 
Moderate to 
severe smokers Human adults Whole brain 
[11C]DAA1
106 (a 
ligand for 
TSPO) via 
PET scan 
When 
activated, 
microglia 
increase the 
expression 
of 
translocator 
protein 
(TSPO). 
↓ binding  Brody et al., 2017 
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Table 2: Antibodies used for immunohistochemistry. 
Antibody target Company and 
catalogue number 
Species 
raised in 
Dilution used Secondary 
Antibody 
BDNF AB1779, 
Millipore 
Corporation, USA 
rabbit 
polyclonal 
1:1000 1:100  
TrkB AB5372, Chemicon 
International, 
Temecula, 
USA 
rabbit 
polyclonal 
1:1500 1:400 
PACAP sc-25439, Santa Cruz 
Biotechnology, Inc 
rabbit 
polyclonal 
1:300 1:400 
PAC1 sc-30018, Santa Cruz 
Biotechnology, Inc 
rabbit 
polyclonal 
1:200 1:100 
GFAP Z0334, Dako, 
Denmark 
rabbit 
polyclonal 
1:1500 1:400 
Iba-1 019-19741 Wako 
Chemicals USA 
rabbit 
polyclonal 
1:1000 1:400 
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